TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/18281553

Clin. Cancer Res. 2008 Feb 15 14 4 1182-91

Download in:

View as

General Info

PMID
18281553